Stimulating Neural Activity to Improve Blood Flow and Reduce Amyloid: Path to Clinical Trials

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 16, 2018

Primary Completion Date

February 10, 2020

Study Completion Date

February 10, 2020

Conditions
Alzheimer Disease
Interventions
DEVICE

Flicker

The Flicker intervention is delivered with the GammaSense Stimulation System by Cognito Therapeutics and involves viewing flickering lights at gamma frequency (like a strobe light but faster) to drive gamma oscillations in visual brain areas. The GammaSense Stimulation System is a device consisting of a pair of opaque glasses with a light-emitting diode (LED) illumination on the interior of the glasses. Headphones worn by the user during the stimulation session provide the auditory stimulation. When activated for the treatment session, the device will generate light and sound oscillations at 40 cycles per second (Hz) for 60 minutes. Participants will use the device daily during their active treatment period.

Trial Locations (1)

30329

12 Executive Park Drive, Atlanta

All Listed Sponsors
collaborator

Georgia Institute of Technology

OTHER

lead

Emory University

OTHER

NCT03543878 - Stimulating Neural Activity to Improve Blood Flow and Reduce Amyloid: Path to Clinical Trials | Biotech Hunter | Biotech Hunter